Medrysone
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
(6S,8S,9S,10R,11S,13R,14S,17S)- 17-acetyl-11-hydroxy-6,10,13-trimethyl-1,2,6,7,8,9, 11,12,14,15,16,17- dodecahydrocyclopenta[a] phenanthren-3-one | |
| Clinical data | |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| MedlinePlus | a606003 |
| Pregnancy category |
|
| Legal status |
|
| Routes of administration | Eye drops |
| Identifiers | |
| CAS Number |
2668-66-8 |
| ATC code | S01BA08 |
| PubChem | CID 247839 |
| IUPHAR/BPS | 7086 |
| DrugBank |
DB00253 |
| ChemSpider |
216968 |
| UNII |
D2UFC189XF |
| KEGG |
D02289 |
| ChEMBL |
CHEMBL1201173 |
| Chemical data | |
| Formula | C22H32O3 |
| Molar mass | 344.488 g/mol |
| |
| |
| | |
Medrysone is a corticosteroid that has been used in optometry, and in ophthalmology for the treatment of eye inflammations.[1][2] It has been discontinued in the US.[2]
See also
References
| ||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Wednesday, September 02, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
